SHEL.UK

2,495

+0.85%↑

BP

373.7

+1.47%↑

SHEL.UK

2,495

+0.85%↑

BP

373.7

+1.47%↑

SHEL.UK

2,495

+0.85%↑

BP

373.7

+1.47%↑

SHEL.UK

2,495

+0.85%↑

BP

373.7

+1.47%↑

SHEL.UK

2,495

+0.85%↑

BP

373.7

+1.47%↑

Search

Smith & Nephew PLC

Slēgts

1,082 0.28

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1071.5

Max

1086

Galvenie mērījumi

By Trading Economics

Ienākumi

107M

Pārdošana

1.4B

P/E

Sektora vidējais

30.871

24.983

EPS

0.376

Dividenžu ienesīgums

2.68

Peļņas marža

7.57

Darbinieki

17,349

EBITDA

260M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+14.21% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.68%

5.79%

Nākamie ieņēmumi

2025. g. 5. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

432M

9.5B

Iepriekšējā atvēršanas cena

1081.72

Iepriekšējā slēgšanas cena

1082

Smith & Nephew PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. maijs 19:39 UTC

Galvenie tirgus virzītāji

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

2025. g. 16. maijs 23:18 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

2025. g. 16. maijs 22:30 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- Update

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. maijs 21:54 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- WSJ

2025. g. 16. maijs 21:22 UTC

Tirgus saruna

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

2025. g. 16. maijs 21:17 UTC

Tirgus saruna

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

2025. g. 16. maijs 21:17 UTC

Top Ziņas

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

2025. g. 16. maijs 21:05 UTC

Tirgus saruna

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

2025. g. 16. maijs 20:55 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 20:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 16. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 16. maijs 20:37 UTC

Top Ziņas

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

2025. g. 16. maijs 20:33 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

2025. g. 16. maijs 20:30 UTC

Iegādes, apvienošanās, pārņemšana

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

2025. g. 16. maijs 20:18 UTC

Top Ziņas

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

2025. g. 16. maijs 20:16 UTC

Top Ziņas

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

2025. g. 16. maijs 20:15 UTC

Peļņas

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

2025. g. 16. maijs 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: William K. Daniel Joins Board

2025. g. 16. maijs 20:10 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: Strategic Investment by KKR Completed

2025. g. 16. maijs 20:05 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 19:38 UTC

Tirgus saruna

Oil Futures Post Second Straight Weekly Gain -- Market Talk

2025. g. 16. maijs 19:07 UTC

Tirgus saruna

U.S. Natural Gas Futures End Week Lower -- Market Talk

2025. g. 16. maijs 18:51 UTC

Top Ziņas

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

2025. g. 16. maijs 18:41 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 18:37 UTC

Tirgus saruna

Gold Futures End Week on Negative Note -- Market Talk

2025. g. 16. maijs 18:35 UTC

Top Ziņas

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

2025. g. 16. maijs 18:32 UTC

Top Ziņas

Trump Floats Plan to Impose New Tariff Rates; Stocks Hold Steady -- WSJ

2025. g. 16. maijs 18:28 UTC

Tirgus saruna

Weaker Dollar Seen as Helping Some Business to Avoid Price Increases -- Market Talk

Salīdzinājums

Cenas izmaiņa

Smith & Nephew PLC Prognoze

Cenas mērķis

By TipRanks

14.21% augšup

Prognoze 12 mēnešiem

Vidējais 1,235.2 GBX  14.21%

Augstākais 1,400 GBX

Zemākais 1,065 GBX

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Smith & Nephew PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

10 ratings

4

Pirkt

6

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

EBITDA

Pamatdarbības peļņa

$

Par Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.